Variant report
Variant | nsv977854 |
---|---|
Chromosome Location | chr15:56583544-56599264 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr15:56584163..56586354-chr15:56587012..56588620,2 | K562 | blood: | |
2 | chr15:56582054..56583561-chr15:56587969..56590161,2 | MCF-7 | breast: | |
3 | chr15:56582054..56583561-chr15:56587969..56590161,2 | MCF-7 | breast: | |
4 | chr15:56584163..56586354-chr15:56587012..56588620,2 | K562 | blood: | |
5 | chr15:56587524..56588313-chr15:56720286..56721333,4 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560975423 | chr15:56583544-56583545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs78545621 | chr15:56583551-56583552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369695210 | chr15:56583571-56583572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs375704171 | chr15:56583610-56583611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565267240 | chr15:56583648-56583649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs180947258 | chr15:56583675-56583676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529113535 | chr15:56583686-56583687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115047956 | chr15:56583767-56583768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183610455 | chr15:56583796-56583797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530270218 | chr15:56583826-56583827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550393395 | chr15:56583864-56583865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150297669 | chr15:56583872-56583873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs34984801 | chr15:56583897-56583898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532822879 | chr15:56583898-56583899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551911619 | chr15:56583905-56583906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565639986 | chr15:56583909-56583910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534438410 | chr15:56583941-56583942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs55751021 | chr15:56583957-56583958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554206313 | chr15:56584025-56584026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2465973 | chr15:56584060-56584061 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs541896621 | chr15:56584064-56584065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373168096 | chr15:56584068-56584069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536893464 | chr15:56584079-56584080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556729386 | chr15:56584089-56584090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569144346 | chr15:56584101-56584102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576761740 | chr15:56584136-56584137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs59808258 | chr15:56584155-56584156 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs35187662 | chr15:56584204-56584205 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs572364046 | chr15:56584219-56584220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541168823 | chr15:56584276-56584277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs189498681 | chr15:56584311-56584312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574975125 | chr15:56584379-56584380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544062530 | chr15:56584389-56584390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563847718 | chr15:56584390-56584391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532713717 | chr15:56584418-56584419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75555209 | chr15:56584449-56584450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371445317 | chr15:56584535-56584536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533918387 | chr15:56584549-56584550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182557049 | chr15:56584551-56584552 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187174801 | chr15:56584555-56584556 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2718949 | chr15:56584591-56584592 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs567856561 | chr15:56584629-56584630 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191999855 | chr15:56584649-56584650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550389058 | chr15:56584663-56584664 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550971723 | chr15:56584666-56584667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570597926 | chr15:56584745-56584746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs539361847 | chr15:56584755-56584756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553185858 | chr15:56584808-56584809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564590124 | chr15:56584865-56584866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1579370 | chr15:56584867-56584868 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Cancer | 21129771 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Congenital diaphragmatic hernia | 21341218 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Amyotrophic lateral sclerosis | 20685689 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:56582000-56584600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr15:56582400-56584800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr15:56582600-56584000 | Weak transcription | Placenta | Placenta |
4 | chr15:56584000-56585600 | Enhancers | Placenta | Placenta |
5 | chr15:56584600-56585200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr15:56584800-56585200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr15:56584800-56585200 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr15:56585800-56586600 | Enhancers | K562 | blood |
9 | chr15:56588200-56588600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr15:56599200-56600800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr15:56599200-56600800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr15:56599200-56601000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr15:56599200-56601000 | Enhancers | Brain Germinal Matrix | brain |